Andreas Kuznik1, Abdulrazaq G Habib, Yukari C Manabe, Mohammed Lamorde. 1. From the *Infectious Diseases Institute, Makerere University College of Health Sciences, Kampala, Uganda; †Celgene Corporation, Summit, NJ; ‡Infectious and Tropical Diseases Unit, Bayero University, Kano, Nigeria; and §Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, MD.
Abstract
BACKGROUND: Untreated syphilis in pregnancy is associated with adverse clinical outcomes to the infant. The study aimed to estimate the public health burden resulting from adverse pregnancy outcomes due to syphilis infection among pregnant women not screened for syphilis in 43 countries in sub-Saharan Africa. METHODS: Estimated country-specific incidence of syphilis was generated from annual number of live births, the proportion of women with at least 1 antenatal care (ANC) visit, the syphilis prevalence rate, and the proportion of women screened for syphilis during ANC.Adverse pregnancy outcome data (stillbirth, neonatal death, low birth weight, and congenital syphilis) were obtained from published sources. Disability-adjusted life-year (DALY) estimates were calculated using undiscounted local life expectancy, the neonatal standard loss function, and relevant disability weights. The model assessed the potential impact of raising ANC coverage to at least 95% and syphilis screening to at least 95% (World Health Organization targets). RESULTS: For all 43 sub-Saharan Africa countries, the estimated incidence of adverse pregnancy outcomes was 205,901 (95% confidence interval [CI], 113,256-383,051) per year, including stillbirth (88,376 [95% CI, 60,854-121,713]), neonatal death (34,959 [95% CI, 23,330-50,076]), low birth weight (22,483 [95% CI, 0-98,847]), and congenital syphilis (60,084 [95% CI, 29,073-112,414]), resulting in approximately 12.5 million DALYs. Countries with the greatest burden are (in DALYs, millions) Democratic Republic of the Congo (1.809), Nigeria (1.598), Ethiopia (1.466), and Tanzania (0.961). Attaining World Health Organization targets could reduce the burden by 8.5 million DALYs. CONCLUSIONS: Substantial infant mortality and morbidity results from maternal syphilis infection concentrated in countries with low access to ANC or low rates of syphilis screening.
BACKGROUND: Untreated syphilis in pregnancy is associated with adverse clinical outcomes to the infant. The study aimed to estimate the public health burden resulting from adverse pregnancy outcomes due to syphilis infection among pregnant women not screened for syphilis in 43 countries in sub-Saharan Africa. METHODS: Estimated country-specific incidence of syphilis was generated from annual number of live births, the proportion of women with at least 1 antenatal care (ANC) visit, the syphilis prevalence rate, and the proportion of women screened for syphilis during ANC.Adverse pregnancy outcome data (stillbirth, neonatal death, low birth weight, and congenital syphilis) were obtained from published sources. Disability-adjusted life-year (DALY) estimates were calculated using undiscounted local life expectancy, the neonatal standard loss function, and relevant disability weights. The model assessed the potential impact of raising ANC coverage to at least 95% and syphilis screening to at least 95% (World Health Organization targets). RESULTS: For all 43 sub-Saharan Africa countries, the estimated incidence of adverse pregnancy outcomes was 205,901 (95% confidence interval [CI], 113,256-383,051) per year, including stillbirth (88,376 [95% CI, 60,854-121,713]), neonatal death (34,959 [95% CI, 23,330-50,076]), low birth weight (22,483 [95% CI, 0-98,847]), and congenital syphilis (60,084 [95% CI, 29,073-112,414]), resulting in approximately 12.5 million DALYs. Countries with the greatest burden are (in DALYs, millions) Democratic Republic of the Congo (1.809), Nigeria (1.598), Ethiopia (1.466), and Tanzania (0.961). Attaining World Health Organization targets could reduce the burden by 8.5 million DALYs. CONCLUSIONS: Substantial infant mortality and morbidity results from maternal syphilis infection concentrated in countries with low access to ANC or low rates of syphilis screening.
Authors: F Tinajeros; D Grossman; K Richmond; M Steele; S G Garcia; L Zegarra; R Revollo Journal: Sex Transm Infect Date: 2006-11-22 Impact factor: 3.519
Authors: Deborah Watson-Jones; John Changalucha; Balthazar Gumodoka; Helen Weiss; Mary Rusizoka; Leonard Ndeki; Anne Whitehouse; Rebecca Balira; James Todd; Donatila Ngeleja; David Ross; Anne Buvé; Richard Hayes; David Mabey Journal: J Infect Dis Date: 2002-09-03 Impact factor: 5.226
Authors: F Terris-Prestholt; D Watson-Jones; K Mugeye; L Kumaranayake; L Ndeki; H Weiss; J Changalucha; J Todd; F Lisekie; B Gumodoka; D Mabey; R Hayes Journal: Sex Transm Infect Date: 2003-10 Impact factor: 3.519
Authors: David C Mabey; Kimberly A Sollis; Helen A Kelly; Adele S Benzaken; Edward Bitarakwate; John Changalucha; Xiang-Sheng Chen; Yue-Ping Yin; Patricia J Garcia; Susan Strasser; Namwinga Chintu; Tikki Pang; Fern Terris-Prestholt; Sedona Sweeney; Rosanna W Peeling Journal: PLoS Med Date: 2012-06-12 Impact factor: 11.069
Authors: Kristina Adachi; Jeffrey D Klausner; Jiahong Xu; Bonnie Ank; Claire C Bristow; Mariza G Morgado; D Heather Watts; Fred Weir; David Persing; Lynne M Mofenson; Valdilea G Veloso; Jose Henrique Pilotto; Esau Joao; Glenda Gray; Gerhard Theron; Breno Santos; Rosana Fonseca; Regis Kreitchmann; Jorge Pinto; Marisa M Mussi-Pinhata; Mariana Ceriotto; Daisy Maria Machado; Yvonne J Bryson; Beatriz Grinsztejn; Francisco I Bastos; George Siberry; Karin Nielsen-Saines Journal: Pediatr Infect Dis J Date: 2016-08 Impact factor: 2.129
Authors: Matthew M Hamill; Kimeze J Mbazira; Agnes N Kiragga; Charlotte A Gaydos; Mary Jett-Goheen; Rosalind Parkes-Ratanshi; Yukari C Manabe; Edith Nakku-Joloba; Anne Rompalo Journal: Sex Transm Dis Date: 2018-12 Impact factor: 2.830
Authors: Enesia Banda Chaponda; R Matthew Chico; Jane Bruce; Charles Michelo; Bellington Vwalika; Sungano Mharakurwa; Mike Chaponda; James Chipeta; Daniel Chandramohan Journal: Am J Trop Med Hyg Date: 2016-09-26 Impact factor: 2.345
Authors: Penny Ford Carleton; Steven Schachter; John A Parrish; John M Collins; J Benjamin Crocker; Ronald F Dixon; Susan Edgman-Levitan; Kent B Lewandrowski; James E Stahl; Catherine Klapperich; Mario Cabodi; Charlotte A Gaydos; Anne M Rompalo; Yukari Manabe; Tza-Huei Wang; Richard Rothman; Chris D Geddes; Lea Widdice; Joany Jackman; Rishi A Mathura; Tiffani Bailey Lash Journal: IEEE J Transl Eng Health Med Date: 2016-08-16 Impact factor: 3.316
Authors: Eline L Korenromp; Guy Mahiané; Jane Rowley; Nico Nagelkerke; Laith Abu-Raddad; Francis Ndowa; Amina El-Kettani; Houssine El-Rhilani; Philippe Mayaud; R Matthew Chico; Carel Pretorius; Kendall Hecht; Teodora Wi Journal: Sex Transm Infect Date: 2017-03-21 Impact factor: 3.519
Authors: David M Goodman; Rohit Ramaswamy; Marc Jeuland; Emmanuel K Srofenyoh; Cyril M Engmann; Adeyemi J Olufolabi; Medge D Owen Journal: PLoS One Date: 2017-07-14 Impact factor: 3.240
Authors: Simon Chengo Masha; Elizabeth Wahome; Mario Vaneechoutte; Piet Cools; Tania Crucitti; Eduard J Sanders Journal: PLoS One Date: 2017-03-31 Impact factor: 3.240
Authors: Jodie Dionne-Odom; Rahel Mbah; Nicole J Rembert; Samuel Tancho; Gregory E Halle-Ekane; Comfort Enah; Thomas K Welty; Pius M Tih; Alan T N Tita Journal: Infect Dis Obstet Gynecol Date: 2016-08-08